Applied Therapeutics, Inc.
APLT
$0.10
-$0.01-8.20%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -3.24% | 26.62% | |||
| Gross Profit | 13.32% | -26.62% | |||
| SG&A Expenses | -28.91% | -25.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.88% | -9.51% | |||
| Operating Income | 22.21% | 9.51% | |||
| Income Before Tax | 10.97% | 2.27% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 10.97% | 2.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 10.97% | 2.27% | |||
| EBIT | 22.21% | 9.51% | |||
| EBITDA | 22.21% | 9.51% | |||
| EPS Basic | 11.22% | 2.46% | |||
| Normalized Basic EPS | 5.66% | 2.44% | |||
| EPS Diluted | 13.00% | 0.46% | |||
| Normalized Diluted EPS | 5.66% | 2.44% | |||
| Average Basic Shares Outstanding | 0.32% | 0.21% | |||
| Average Diluted Shares Outstanding | 0.32% | 0.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||